Copy number alteration profiling facilitates differential diagnosis between ossifying fibroma and fibrous dysplasia of the jaws

Abstract

Ossifying fibroma (OF) and fibrous dysplasia (FD) are two fibro-osseous lesions with overlapping clinicopathological features, making diagnosis challenging. In this study, we applied a whole-genome shallow sequencing approach to facilitate differential diagnosis via precise profiling of copy number alterations (CNAs) using minute amounts of DNA extracted from morphologically correlated microdissected tissue samples. Freshly frozen tissue specimens from OF (n = 29) and FD (n = 28) patients were obtained for analysis. Lesion fibrous tissues and surrounding normal tissues were obtained by laser capture microdissection (LCM), with ~30–50 cells (5 000–10 000 µm²) per sample. We found that the rate of recurrent CNAs in OF cases was much higher (44.8%, 13 of 29) than that in FD cases (3.6%, 1 of 28). Sixty-nine percent (9 of 13) of the CNA-containing OF cases involved segmental amplifications and deletions on Chrs 7 and 12. We also identified eight CNA-associated genes (HILPDA, CALD1, C1GALT1, MICALL2, PHF14, AIMP2, MDM2, and CDK4) with amplified expression, which was consistent with the copy number changes. We further confirmed a jaw lesion with a previous uncertain diagnosis due to its ambiguous morphological features and the absence of GNAS mutation as OF based on the typical Chr 12 amplification pattern in its CNA profile. Moreover, analysis of a set of longitudinal samples collected from an individual with a cellular lesion in suspicion of OF at the first surgery, recurrence and the latest malignant transformation revealed identical CNA patterns at the three time points, suggesting that copy number profiling can be used as an important tool to identify borderline lesions or lesions with malignant potential. Overall, CNA profiling of fibro-osseous lesions can greatly improve differential diagnosis between OF and FD and help predict disease progression.

References

[1] MacDonald-Jankowski DS. Fibro-osseous lesions of the face and jaws. Clin. Radiol., 2004, 59: 11-25.

[2] Speight PM, Takata T. New tumour entities in the 4th edition of the World Health Organization Classification of Head and Neck tumours: odontogenic and maxillofacial bone tumours. Virchows Arch., 2018, 472: 331-339.

[3] El⁃Naggar AK, Chan JKC, Grandis JR, Takashi T. & Slootweg PJ, eds. WHO classification of head and neck tumours. Lyon: IARC Press, 251–255 (2017)..

[4] Mainville GN, Turgeon DP, Kauzman A. Diagnosis and management of benign fibro-osseous lesions of the jaws: a current review for the dental clinician. Oral. Dis., 2017, 23: 440-450.

[5] Toyosawa S, . Ossifying fibroma vs fibrous dysplasia of the jaw: molecular and immunological characterization. Mod. Pathol., 2007, 20: 389-396.

[6] Ahmad M, Gaalaas L. Fibro-osseous and other lesions of bone in the jaws. Radiol. Clin. North Am., 2018, 56: 91-104.

[7] Robinson C, Collins MT, Boyce AM. Fibrous dysplasia/McCune-Albright syndrome: clinical and translational perspectives. Curr. Osteoporos. Rep., 2016, 14: 178-186.

[8] Javaid MK, . Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium. Orphanet J. Rare Dis., 2019, 14

[9] Gondivkar SM, Gadbail AR, Chole R, Parikh RV, Balsaraf S. Ossifying fibroma of the jaws: report of two cases and literature review. Oral. Oncol., 2011, 47: 804-809.

[10] Liu Y, . Ossifying fibromas of the jaw bone: 20 cases. Dentomaxillofac. Radiol., 2010, 39: 57-63.

[11] Eversole LR, Leider AS, Nelson K. Ossifying fibroma: a clinicopathologic study of sixty-four cases. Oral Surg. Oral Med. Oral Pathol., 1985, 60: 505-511.

[12] Alawi F. Benign fibro-osseous diseases of the maxillofacial bones. A review and differential diagnosis. Am. J. Clin. Pathol., 2002, 118(Suppl): S50-S70.

[13] Koury ME, Regezi JA, Perrott DH, Kaban LB. “Atypical” fibro-osseous lesions: diagnostic challenges and treatment concepts. Int. J. Oral Maxillofac. Surg., 1995, 24: 162-169.

[14] Slootweg PJ. Maxillofacial fibro-osseous lesions: classification and differential diagnosis. Semin. Diagn. Pathol., 1996, 13: 104-112.

[15] Brannon RB, Fowler CB. Benign fibro-osseous lesions: a review of current concepts. Adv. Anat. Pathol., 2001, 8: 126-143.

[16] Tabareau-Delalande F, . Diagnostic value of investigating GNAS mutations in fibro-osseous lesions: a retrospective study of 91 cases of fibrous dysplasia and 40 other fibro-osseous lesions. Mod. Pathol., 2013, 26: 911-921.

[17] Xu R, . Gα(s) signaling controls intramembranous ossification during cranial bone development by regulating both Hedgehog and Wnt/β-catenin signaling. Bone Res., 2018, 6: 33.

[18] Pereira T, Gomes CC, Brennan PA, Fonseca FP, Gomez RS. Fibrous dysplasia of the jaws: Integrating molecular pathogenesis with clinical, radiological, and histopathological features. J. Oral. Pathol. Med, 2019, 48: 3-9.

[19] Cleven AHG, Schreuder WH, Groen E, Kroon HM, Baumhoer D. Molecular findings in maxillofacial bone tumours and its diagnostic value. Virch. Arch., 2020, 476: 159-174.

[20] Lauer S, Gresham D. An evolving view of copy number variants. Curr. Genet., 2019, 65: 1287-1295.

[21] Liu P, Carvalho CM, Hastings PJ, Lupski JR. Mechanisms for recurrent and complex human genomic rearrangements. Curr. Opin. Genet. Dev., 2012, 22: 211-220.

[22] Mikhail FM. Copy number variations and human genetic disease. Curr. Opin. Pediatr., 2014, 26: 646-652.

[23] Cooper GM, . A copy number variation morbidity map of developmental delay. Nat. Genet., 2011, 43: 838-846.

[24] Li W, Olivier M. Current analysis platforms and methods for detecting copy number variation. Physiol. Genomics, 2013, 45: 1-16.

[25] Stankiewicz P, Lupski JR. Structural variation in the human genome and its role in disease. Annu. Rev. Med., 2010, 61: 437-455.

[26] Almal SH, Padh H. Implications of gene copy-number variation in health and diseases. J. Hum. Genet., 2012, 57: 6-13.

[27] Zhang L, . Efficient CNV breakpoint analysis reveals unexpected structural complexity and correlation of dosage-sensitive genes with clinical severity in genomic disorders. Hum. Mol. Genet., 2017, 26: 1927-1941.

[28] Tabareau-Delalande F, . Chromosome 12 long arm rearrangement covering MDM2 and RASAL1 is associated with aggressive craniofacial juvenile ossifying fibroma and extracranial psammomatoid fibro-osseous lesions. Mod. Pathol., 2015, 28: 48-56.

[29] Liang Q, . Quantitative analysis of activating alpha subunit of the G protein (Gsα) mutation by pyrosequencing in fibrous dysplasia and other bone lesions. J. Mol. Diagn., 2011, 13: 137-142.

[30] Shi RR, Li XF, Zhang R, Chen Y, Li TJ. GNAS mutational analysis in differentiating fibrous dysplasia and ossifying fibroma of the jaw. Mod. Pathol., 2013, 26: 1023-1031.

[31] Pimenta FJ, . HRPT2 gene alterations in ossifying fibroma of the jaws. Oral. Oncol., 2006, 42: 735-739.

[32] Garcia RA, Inwards CY, Unni KK. Benign bone tumors-recent developments. Semin. Diagn. Pathol., 2011, 28: 73-85.

[33] Sawyer JR, Tryka AF, Bell JM, Boop FA. Nonrandom chromosome breakpoints at Xq26 and 2q33 characterize cemento-ossifying fibromas of the orbit. Cancer, 1995, 76: 1853-1859.

[34] Dujardin F, . MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Mod. Pathol., 2011, 24: 624-637.

[35] Guérin M, . A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification. Hum. Pathol., 2016, 50: 70-78.

[36] Höglund M, Gisselsson D, Hansen GB, Säll T, Mitelman F. Multivariate analysis of chromosomal imbalances in breast cancer delineates cytogenetic pathways and reveals complex relationships among imbalances. Cancer Res., 2002, 62: 2675-2680.

[37] Gao R, . Punctuated copy number evolution and clonal stasis in triple-negative breast cancer. Nat. Genet., 2016, 48: 1119-1130.

[38] Harrel M, Hughes-Stamm S. A powder-free DNA extraction workflow for skeletal samples. J. For. Sci., 2020, 65: 601-609.

[39] Loreille OM, Diegoli TM, Irwin JA, Coble MD, Parsons TJ. High efficiency DNA extraction from bone by total demineralization. For. Sci. Int. Genet., 2007, 1: 191-195.

[40] Del Valle C, Rodríguez A, Espinoza M. Comparison of three methods for DNA extraction from bone remains. Rev. Biol. Trop., 2004, 52: 717-725.

[41] Cheng L, . Identification of genes with a correlation between copy number and expression in gastric cancer. BMC Med. Genomics, 2012, 5

[42] Junnila S, Kokkola A, Karjalainen-Lindsberg ML, Puolakkainen P, Monni O. Genome-wide gene copy number and expression analysis of primary gastric tumors and gastric cancer cell lines. BMC Cancer, 2010, 10

[43] Sirvent N, . Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR. Am. J. Surg. Pathol., 2007, 31: 1476-1489.

[44] Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet, 2011, 17: 10-12.

[45] Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat. Methods, 2012, 9: 357-359.

[46] Seshan VE, O. A. DNAcopy: DNA Copy Number Data Analysis R Package Version 1.64.0 (2020).

[47] Olshen AB, Venkatraman ES, Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics, 2004, 5: 557-572.

[48] Affymetrix. Median of the Absolute Values of All Pairwise Differences and Quality Control on Affymetrix Genome-Wide Human SNP Array 6.0. Affymetrix White Paper (2008).

Funding

National Natural Science Foundation of China (National Science Foundation of China)(81671006, 81700994, 22050004, 22050002)

CAMS Innovation Fund for Medical Sciences (2019-I2M-5-038).